On May 19, 2022, The Siga Technologies, Inc. (NASDAQ: SIGA) announced the approval of its intravenous (IV) formulation of TPOXX® (tecovirimat) by the U.S. Food and Drug Administration (FDA). The drug is intended to treat smallpox, and the approval offers a much-needed alternative to those...
Collaboration Agreement with Sanofi IGM Biosciences, Inc. (NASDAQ: IGMS), a biotechnology company leveraging its expertise in Immunoglobulin M (IgM) antibodies, announced an exclusive worldwide collaboration agreement with Sanofi (NASDAQ: SNY). The agreement is for developing and commercializing IgM antibody agonists against six initial targets, three in...
Aligos Therapeutics, Inc. (NASDAQ: ALGS), a clinical-stage biotechnology Company announced the discontinuation of dosing in the first cohort of its candidate ALG-020572, intended for the treatment of chronic hepatitis B. The dosing was stopped after a patient experienced a serious adverse event (SAE) and a...
On March 14 2022, The Nektar Therapeutics (NASDAQ: NKTR) announced that a review by an independent Data Monitoring Committee (DMC) evaluating the safety and efficacy of bempegaldesleukin in combination with Opdivo (nivolumab), revealed that the study has failed to meet the primary endpoints of progression-free...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a clinical-stage biotechnology Company is focussed on creating novel therapeutics for the treatment of neurodegenerative diseases such as ALS and Alzheimer’s. The Company is awaiting the decision on its NDA for AMX0035 (sodium phenylbutyrate (PB) and taurursodiol (TURSO; also...
8th March celebrates the cultural, political and socioeconomic achievements of women from different strata and geographies across the globe. Femtech, a category that leverages technology to address issues related to women’s health, is poised to become a $50 billion dollar industry by year 2025, according...
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced that it is pausing enrolment for an ongoing late-stage study evaluating its lead COVID-19 vaccine candidate INO-4800, as lab tests show that the candidate had significantly lower levels of antibodies against the Omicron variant. The Company is now planning changes...
Shelving of Gene Therapy Spin Off Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment of rare metabolic diseases, announced that the proposed Business Combination Agreement with ARYA Sciences Acquisition Corp IV, a special purpose acquisition company has been mutually terminated owing...
Kodiak Sciences, Inc. (NASDAQ: KOD), a clinical-stage biotechnology Company focused on creating novel therapeutics for the treatment of retinal diseases, announced top-line results from a Phase 2b/3 clinical trial evaluating KSI-301, a novel antibody biopolymer conjugate, intended for the treatment of neovascular (wet) age-related macular...
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) is a biopharmaceutical Company aiming to create novel therapeutics for the treatment of progressive non-viral liver diseases. The Company’s lead compound Ocalive or obeticholic acid (OCA), is an analog of the bile acid chenodeoxycholic acid (CDCA), which is being evaluated for...
